Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AUGUST J. T., NELSON D. H., THORN G. W. Aldosterone. N Engl J Med. 1958 Nov 13;259(20):967–concl. doi: 10.1056/NEJM195811132592005. [DOI] [PubMed] [Google Scholar]
- AXELRAD B. J., CATES J. E., JOHNSON B. B., LUETSCHER J. A., Jr Aldosterone in urine of normal man and of patients with oedema; its increased recovery after hydrolysis with acid and with beta-glucuronidase. Br Med J. 1955 Jan 22;1(4907):196–199. doi: 10.1136/bmj.1.4907.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BARTTER F. C., DUNCAN L. E., Jr, LIDDLE G. W. The effect of changes in body sodium on extracellular fluid volume and aldosterone and sodium excretion by normal and edematous men. J Clin Invest. 1956 Nov;35(11):1299–1305. doi: 10.1172/JCI103385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BAYLISS R. I., MARRACK D., PIRKIS J., REES J. R., ZILVA J. F. Chlorothiazide: an oral diuretic. Lancet. 1958 Jan 18;1(7012):120–124. doi: 10.1016/s0140-6736(58)90610-x. [DOI] [PubMed] [Google Scholar]
- BIRKENFELD L. W., LEIBMAN J., O'MEARA M. P., EDELMAN I. S. Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure. J Clin Invest. 1958 May;37(5):687–698. doi: 10.1172/JCI103655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BOLTE E., VERDY M., MARC-AURELE J., BROUILLET J., BEAUREGARD P., GENEST J. Studies on new diuretic compounds: spirolactone and chlorothiazide. Can Med Assoc J. 1958 Dec 1;79(11):881–888. [PMC free article] [PubMed] [Google Scholar]
- DYRENFURTH I., STACEY C. H., BECK J. C., VENNING E. H. Aldosterone excretion in patients with cirrhosis of the liver. Metabolism. 1957 Nov;6(6 Pt 1):544–555. [PubMed] [Google Scholar]
- KAGAWA C. M., CELLA J. A., VAN ARMAN C. G. Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt. Science. 1957 Nov 15;126(3281):1015–1016. doi: 10.1126/science.126.3281.1015. [DOI] [PubMed] [Google Scholar]
- KERR D. N., READ A. E., HASLAM R. M., SHERLOCK S. The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis. Lancet. 1958 Nov 22;2(7056):1084–1087. doi: 10.1016/s0140-6736(58)92464-4. [DOI] [PubMed] [Google Scholar]
- LIDDLE G. W. Sodium diuresis induced by steroidal antagonists of aldosterone. Science. 1957 Nov 15;126(3281):1016–1018. doi: 10.1126/science.126.3281.1016. [DOI] [PubMed] [Google Scholar]
- LUETSCHER J. A., Jr, JOHNSON B. B. Observations on the sodium-retaining corticoid (aldosterone) in the urine of children and adults in relation to sodium balance and edema. J Clin Invest. 1954 Nov;33(11):1441–1446. doi: 10.1172/JCI103022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LUETSCHER J. A., Jr, NEHER R., WETTSTEIN A. Isolation of crystalline aldosterone from the urine of a nephrotic patient. Experientia. 1954 Nov 15;10(11):456–458. doi: 10.1007/BF02170397. [DOI] [PubMed] [Google Scholar]
- ROSS E. J., BETHUNE J. E. Antagonism between the effect of aldosterone and a synthetic steroid lactone on the renal excretion of sodium and potassium in man. Lancet. 1959 Jan 17;1(7064):127–129. doi: 10.1016/s0140-6736(59)90006-6. [DOI] [PubMed] [Google Scholar]
- SALASSA R. M., MATTOX V. R., POWER M. H. Effect of an aldosterone antagonist on sodium and potassium excretion in primary hyperaldosteronism. J Clin Endocrinol Metab. 1958 Jul;18(7):787–789. doi: 10.1210/jcem-18-7-787. [DOI] [PubMed] [Google Scholar]
- SINGER B., WENER J. Excretion of sodium-retaining substances in patients with congestive heart failure. Am Heart J. 1953 Jun;45(6):795–801. doi: 10.1016/0002-8703(53)90127-6. [DOI] [PubMed] [Google Scholar]